Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
B3GAT1 divergent transcript (B3GAT1-DT) is a long non-coding RNA gene located near the B3GAT1 locus, listed as LOC283177, and is also known as AP004608.1[3][4]. It belongs to the lncRNA subclass and may be involved in regulation through divergent transcription mechanisms, but there is no evidence for protein-coding function, receptor status, or classic molecular target classification[3][5]. Disease association is limited; it has been referenced in the context of prostate cancer[3]. No drugs, mechanisms of action, or biomarkers are recorded for this transcript, and its biological role remains unclear, representing a possible regulatory element rather than a classic druggable target. Divergent transcription per se is a process linked with gene regulation and origination of novel genes but does not entail receptor or enzyme activity[5]. Key distinctions: - B3GAT1-DT is not the protein-coding B3GAT1 enzyme[1]; the latter is a glucuronyltransferase and is a molecular target. - B3GAT1-DT is an RNA transcript, not known to encode any protein or receptor. - Information on function and significance is very limited. If a therapeutic target is required, consult entries for the protein-coding gene B3GAT1 ("Beta-1,3-glucuronyltransferase 1")[1], not its divergent lncRNA transcript.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on B3GAT1 divergent transcript (B3GAT1-DT).